![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
C-EDGE IBLD: Efficacy and Safety of Elbasvir/Grazoprevir in Patients With
Chronic Hepatitis C Virus Infection and Inherited Blood Disorders
|
|
|
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
Hezode C1; Colombo M2; Spengler U3; Ben-Ari Z4; Strasser S5; Lee WM6; Morgan L7; Qiu J7; Hwang P7;
Robertson M7; Nguyen B-Y7; Barr E7; Wahl J7; Haber B7; Talwani R7; Di Marco V8
1Henri Mondor Hospital, Paris, France; 2University of Milan, Milan, Italy; 3University Hospital Bonn, Bonn, Germany; 4Sheba Medical Center, Ramat Gan, Israel; 5University of Sydney, Sydney, NSW, Australia; 6University of Texas
Southwestern Medical Center, Dallas, TX, USA; 7Merck & Co., Inc., Kenilworth, NJ, USA; 8University of Palermo, Palermo, Italy
![EASL1](../images/042816/042816-2/EASL1.gif)
![EASL2](../images/042816/042816-2/EASL2.gif)
![EASL3](../images/042816/042816-2/EASL3.gif)
![EASL4](../images/042816/042816-2/EASL4.gif)
![EASL5](../images/042816/042816-2/EASL5.gif)
![EASL6](../images/042816/042816-2/EASL6.gif)
![EASL7](../images/042816/042816-2/EASL7.gif)
![EASL8](../images/042816/042816-2/EASL8.gif)
![EASL9](../images/042816/042816-2/EASL9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|